Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP100195.RAFfkGdGVT-PHeHDqKhSV4zKGl02txS_bDybQ0jbeQ07w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP100195.RAFfkGdGVT-PHeHDqKhSV4zKGl02txS_bDybQ0jbeQ07w130_assertion type Assertion NP100195.RAFfkGdGVT-PHeHDqKhSV4zKGl02txS_bDybQ0jbeQ07w130_head.
- NP100195.RAFfkGdGVT-PHeHDqKhSV4zKGl02txS_bDybQ0jbeQ07w130_assertion description "[p57 (Kip2) down-regulation is a well-established feature of urothelial carcinoma/, this down-regulation of cyclin-dependent kinase inhibitors supports the proliferation phase of oncogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100195.RAFfkGdGVT-PHeHDqKhSV4zKGl02txS_bDybQ0jbeQ07w130_provenance.
- NP100195.RAFfkGdGVT-PHeHDqKhSV4zKGl02txS_bDybQ0jbeQ07w130_assertion evidence source_evidence_literature NP100195.RAFfkGdGVT-PHeHDqKhSV4zKGl02txS_bDybQ0jbeQ07w130_provenance.
- NP100195.RAFfkGdGVT-PHeHDqKhSV4zKGl02txS_bDybQ0jbeQ07w130_assertion SIO_000772 18822693 NP100195.RAFfkGdGVT-PHeHDqKhSV4zKGl02txS_bDybQ0jbeQ07w130_provenance.
- NP100195.RAFfkGdGVT-PHeHDqKhSV4zKGl02txS_bDybQ0jbeQ07w130_assertion wasDerivedFrom lhgdn-20090331 NP100195.RAFfkGdGVT-PHeHDqKhSV4zKGl02txS_bDybQ0jbeQ07w130_provenance.
- NP100195.RAFfkGdGVT-PHeHDqKhSV4zKGl02txS_bDybQ0jbeQ07w130_assertion wasGeneratedBy ECO_0000203 NP100195.RAFfkGdGVT-PHeHDqKhSV4zKGl02txS_bDybQ0jbeQ07w130_provenance.